OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics

Author's Avatar
Jun 08, 2020
Article's Main Image

Avant Diagnostics provides personalized medicine data for physicians and measures the activation state of key drug targets and signaling pathways for Biopharmas through its Theralink® assays